Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study

about

Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study

Item

http://www.wikidata.org/entity/Q58709957

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Switching from Flash Glucose M ...... Phase of the I HART CGM Study

@en

Switching from Flash Glucose M ...... Phase of the I HART CGM Study

@nl

type

Item

label

Switching from Flash Glucose M ...... Phase of the I HART CGM Study

@en

Switching from Flash Glucose M ...... Phase of the I HART CGM Study

@nl

prefLabel

Switching from Flash Glucose M ...... Phase of the I HART CGM Study

@en

Switching from Flash Glucose M ...... Phase of the I HART CGM Study

@nl

P1476

Switching from Flash Glucose M ...... Phase of the I HART CGM Study

@en

P2093

Monika Reddy

http://www.w3.org/2001/XMLSchema#string

Narvada Jugnee

http://www.w3.org/2001/XMLSchema#string

Sinthuka Anantharaja

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes

Increased mortality of patients with diabetes reporting severe hypoglycemia.

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.

Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs.

Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.

Keeping safe. Continuous glucose monitoring (CGM) in persons with Type 1 diabetes and impaired awareness of hypoglycaemia: a qualitative study.

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.

Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.

P304

751-757

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/DIA.2018.0252

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nick Oliver

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30265562

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

endocrinology

hypoglycemia

medical laboratory technology

glucose

glucose monitoring

P932

6208158

http://www.w3.org/2001/XMLSchema#string